EBS
Emergent Biosolutions Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.07
-0.06 ▼ -0.74%
🌙 3월 13일 6:24 PM ET (한국 3/14 07:24)
$8.00
-0.07 ▼ -0.87%
| Index | RUT | P/E | 9.73 | EPS (ttm) | 0.83 | Insider Own | 3.8% | Shs Outstand | 0.05B | Perf Week | -2.65% |
| Market Cap | 0.42B | Forward P/E | - | EPS next Y | - | Insider Trans | -3.86% | Shs Float | 0.05B | Perf Month | -26.84% |
| Enterprise Value | 0.79B | PEG | - | EPS next Q | -0.25 | Inst Own | 84.21% | Short Float | 18.04% | Perf Quarter | -30.19% |
| Income | 0.05B | P/S | 0.56 | EPS this Y | -66.01% | Inst Trans | 4.82% | Short Ratio | 9.45 | Perf Half Y | -1.94% |
| Sales | 0.74B | P/B | 0.8 | EPS next 5Y | - | ROA | 3.86% | Short Interest | 8.99M | Perf YTD | -34.71% |
| Book/sh | 10.03 | P/C | 2 | EPS past 3/5Y | - -30.38% | ROE | 10.46% | 52W High | -42.6% ($14.06) | Perf Year | 46.46% |
| Cash/sh | 4.04 | P/FCF | 2.66 | Sales past 3/5Y | -12.72% -13.74% | ROIC | 4.76% | 52W Low | 100.75% ($4.02) | Perf 3Y | -15.32% |
| Dividend Est. | - | EV/EBITDA | 3.84 | EPS Y/Y TTM | 126.18% | Gross Margin | 47.07% | Volatility(W/M) | 4.19% 5.78% | Perf 5Y | -91.05% |
| Dividend TTM | - | EV/Sales | 1.07 | Sales Y/Y TTM | -28.81% | Oper. Margin | 14.71% | ATR (14) | 0.58 | Perf 10Y | -74.87% |
| Dividend Ex-Date | - | Quick Ratio | 2.41 | EPS Q/Q | -80.43% | Profit Margin | 7.08% | RSI (14) | 27.73 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.01 | Sales Q/Q | -23.63% | SMA20 | -15.47% ($9.55) | Beta | 2.41 | Target Price | $12 |
| Payout | - | Debt/Eq | 1.12 | Earnings | 2000000 | SMA50 | -26.21% ($10.94) | Rel Volume | 0.67 | Prev Close | $8.13 |
| Employees | 900 | LT Debt/Eq | 1.11 | EPS/Sales Surpr. | -490.91% -31.63% | SMA200 | -13.52% ($9.33) | Avg Volume(3M) | 0.95M | Price | $8.07 |
| IPO | 2006/11/15 | Option/Short | Yes/Yes | Trades | 5439 | Volume | 641,430 | Change | -0.74% |
뉴스 로딩 중...